| Financial Year |
March 31 2023 |
| Monetary Funds |
5,330,115,565.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
39,738,438.75 |
| Accounts Receivable |
6,857,416,276.69 |
| Advances to Suppliers |
657,616,096.99 |
| Other Receivables |
218,415,822.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,337,017,034.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
194,619,276.19 |
| Total Current Assets |
20,405,579,360.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,543,322.74 |
| Long-term Equity Investment |
90,668,835.21 |
| Investment Properties |
67,210,527.65 |
| Fixed Assetes |
5,148,026,417.56 |
| Under-construction Projects |
1,082,876,774.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,508,689,502.48 |
| R&D expenses |
582,038,393.45 |
| Goodwill |
5,197,198,267.00 |
| Long-Term Deferred and Prepaid Expenses |
147,869,013.50 |
| Deferred Income Tax Assets |
585,242,826.54 |
| Other Non-Current Assets |
331,420,555.16 |
| Sub-Total of Non-Current Assets |
17,474,274,655.89 |
| Total Assets |
37,879,854,016.08 |
| Short-Term Loans |
1,434,057,876.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
741,233,214.61 |
| Accounts Payable |
2,380,306,638.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
976,352,228.75 |
| Taxes Payable |
474,958,448.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,049,070,855.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
190,274,419.63 |
| Other Current Liabilities |
343,668,371.93 |
| Sub-Total of Current Liabilities |
13,201,541,932.91 |
| Long-term Loans |
117,713,089.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,693,777.41 |
| Special Payable |
-- |
| Estimatied Liabilities |
34,748,616.57 |
| Deferred Income Tax Liabilities |
435,861,834.31 |
| Other Non-Current Liabilities |
38,274,308.93 |
| Sub-Total of Non-Current Liabilities |
1,527,249,304.28 |
| Total Liabilities |
14,728,791,237.19 |
| Paid-In Capital(Or Share Stock) |
988,346,000.00 |
| Capital Surplus |
1,817,962,952.81 |
| Surplus Reserve |
535,907,182.46 |
| LESS:Treasury Stock |
143,571,233.31 |
| Undistributed Profits |
14,912,465,539.00 |
| Minority Stockholder's Interest |
4,973,484,838.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,177,577,940.58 |
| Owner's Equity（Stockholder's Equity） |
23,151,062,778.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,879,854,016.08 |
